Canada markets open in 2 hours 7 minutes

Neuronetics, Inc. (STIM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.5200+0.0700 (+2.03%)
At close: 04:00PM EST
3.5200 0.00 (0.00%)
After hours: 04:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close3.4500
Open3.4300
Bid2.0000 x 1800
Ask4.9800 x 900
Day's Range3.4300 - 3.6650
52 Week Range3.3400 - 21.0400
Volume253,747
Avg. Volume240,569
Market Cap92.815M
Beta (5Y Monthly)2.38
PE Ratio (TTM)N/A
EPS (TTM)-1.1510
Earnings DateFeb. 28, 2022 - Mar. 04, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.33
  • GlobeNewswire

    NeuroStar Advanced Therapy for Mental Health Recognized as Top Neuromodulation Solution Provider in 2021

    Technology is awarded for its advances in mental healthMALVERN, Pa., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, is named Top Neuromodulation Solution Provider in 2021 by MedTech Outlook magazine. NeuroStar is the leading transcranial magnetic stimulation (TMS) treatment for major depres

  • GlobeNewswire

    Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2021 Financial Results

    MALVERN, Pa., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced certain preliminary unaudited fourth quarter and full year 2021 revenue results. Fourth Quarter 2021Preliminary unaudited total revenue for the fourth quarter of 2021 is expected to be in the range of approximately

  • GlobeNewswire

    Neuronetics Announces 510(k) Clearance of MT Cap Technology for NeuroStar® Advanced Therapy for Mental Health

    Technology will save practitioners and patients time during motor threshold determinationMALVERN, Pa., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced today that they have received 510(k) clearance on their MT Cap technology for NeuroStar® Advanced Therapy for Mental Health. A limi